Rhodotorula fungemia of an intensive care unit patient and review of published cases.

Mycopathologia
Anastasia SpiliopoulouMyrto Christofidou

Abstract

Rhodotorula species are commensal yeasts that have emerged as a cause of life-threatening fungemia in severely immunocompromised patients. A case of Rhodotorula mucilaginosa fungemia in a 48-year-old woman that had undergone consecutive abdominal surgeries due to ovarian cancer and bowel necrosis while she was receiving fluconazole prophylaxis is presented. Several risk factors were identified such as presence of central venous catheters, solid organ neoplasm, abdominal surgery and administration of antibiotics. Identification was performed using commercial systems. The yeast was resistant to fluconazole, posaconazole and voriconazole and to echinocandins, whereas MIC to amphotericin B was 1.5 mg/L. Furthermore, published cases of Rhodotorula spp fungemia during the last decade are reviewed. In conclusion, Rhodotorula spp must be considered a potential pathogen in patients with immunosupression and central venous catheters. Correct identification is mandatory for appropriate management, as Rhodotorula spp are resistant to antifungal agents, such as fluconazole and echinocandins.

References

Apr 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T E KiehnD Armstrong
Mar 1, 1967·Archives of Internal Medicine·D B LouriaP Lieberman
Oct 1, 1995·Clinical Microbiology Reviews·K C Hazen
Jun 8, 2000·International Journal of Systematic and Evolutionary Microbiology·J W FellA Statzell-Tallman
Apr 12, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V Petrocheilou-PaschouS Stamatelopoulos
Apr 17, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Jin-Won ChungYang Soo Kim
Feb 8, 2003·Journal of Clinical Microbiology·Po-Ren HsuehKwen-Tay Luh
Jun 6, 2003·Infection·M MaederH F Günthard
Nov 8, 2003·Journal of Clinical Microbiology·Aimee K ZaasJohn R Perfect
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V Lo ReI Nachamkin
Jan 7, 2005·Journal of Clinical Microbiology·D J DiekemaM A Pfaller
Feb 8, 2005·The Journal of Antimicrobial Chemotherapy·Alicia Gomez-LopezManuel Cuenca-Estrella
Apr 20, 2005·Journal of Pediatric Hematology/oncology·Gilberto Comarú PasqualottoAlgemir Lunardi Brunetto
Mar 10, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R PerniolaR Longo
May 30, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Diamantis KofteridisGeorge Samonis
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luciano W LunardiLuciano Z Goldani
Jul 4, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·D J RiedelG N Forrest
Sep 13, 2008·Revista iberoamericana de micología·Felipe F Tuon, Silvia F Costa
Jan 31, 2009·Medical Mycology·Gisele M Duboc De AlmeidaMarcelo N Burattini
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Manuel Cuenca-EstrellaJuan L Rodriguez-Tudela
Mar 27, 2010·Mycoses·J García-SuárezC Burgaleta
Jan 29, 2011·The Lancet Infectious Diseases·Marisa H MiceliSamuel A Lee
May 9, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Maiken C ArendrupUNKNOWN EUCAST-AFST

❮ Previous
Next ❯

Citations

Nov 21, 2017·F1000Research·Anna SkiadaMaria Drogari-Apiranthitou
Jun 12, 2019·Antimicrobial Agents and Chemotherapy·Andrew M BormanElizabeth M Johnson
Jun 3, 2017·International Journal of Health Care Quality Assurance·David W BorowskiTalvinder S Gill
Jan 8, 2014·Infection & chemotherapy·Hyun Ah KimSeong-Yeol Ryu
Sep 30, 2018·Mycoses·Petros IoannouGeorge Samonis
Oct 24, 2012·Interdisciplinary Perspectives on Infectious Diseases·Fernanda Wirth, Luciano Z Goldani
Dec 7, 2018·Medical Mycology Journal·Yuhko SuzukiHikaru Kume
Sep 19, 2017·Mycoses·Iker Falces-RomeroJulio García-Rodríguez
Oct 17, 2019·Microorganisms·Graciéle C A de MenezesLuiz H Rosa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Jesús Monterrubio VillarJuan Diego Jiménez Delgado
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Jesús Monterrubio VillarJuan Diego Jiménez Delgado
Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Jesuś Monterrubio VillarJuan Diego Jiménez Delgado
© 2021 Meta ULC. All rights reserved